Author:
Föll D.,Wittkowski H.,Hinze C.
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Avau A, Mitera T, Put S et al (2014) Systemic juvenile idiopathic arthritis-like syndrome in mice following stimulation of the immune system with Freund’s complete adjuvant: regulation by interferon-gamma. Arthritis Rheumatol 66:1340–1351
2. Brown RA, Henderlight M, Do T et al (2018) Neutrophils from children with systemic juvenile idiopathic arthritis exhibit persistent proinflammatory activation despite long-standing clinically inactive disease. Front Immunol 9:2995
3. De Benedetti F, Brogan P, Grom A et al (2019) Emapalumab, an interferon gamma (IFN-Y)-blocking monoclonal antibody, in patients with macrophage activation syndrome (MAS) complicating systemic juvenile idiopathic arthritis (SJIA). Ann Rheum Dis 78:178
4. De Benedetti F, Brunner HI, Ruperto N et al (2012) Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med 367:2385–2395
5. Foell D, Wittkowski H, Kessel C et al (2013) Proinflammatory S100A12 can activate human monocytes via Toll-like receptor 4. Am J Respir Crit Care Med 187:1324–1334
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献